Arax Advisory Partners’s Select Medical SEM Stock Holding History

Arax Advisory Partners’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Buy	13,693 +11,257	+462%	+$185K	﹤0.01%	2168
2026 Q1	$39.7K	Sell	2,436 -10,482	-81%	-$164K	﹤0.01%	1777
2025 Q4	$192K	Sell	12,918 -75	-0.6%	-$1.06K	0.01%	1063
2025 Q3	$167K	Buy	12,993 +12,629	+3,470%	+$168K	﹤0.01%	1328
2025 Q2	$5.53K	Buy	364 +323	+788%	+$5.04K	﹤0.01%	2214
2025 Q1	$685	Sell	41 -278	-87%	-$5.12K	﹤0.01%	2455
2024 Q4	$6.01K	Sell	319 -280	-47%	-$5.4K	﹤0.01%	1675
2024 Q3	$11.3K	Hold	599	–	–	﹤0.01%	1357
2024 Q2	$11.3K	Buy	+599	New	+$10.2K	﹤0.01%	1213

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Arax Advisory Partners's SEM Position: Q2 2026 in Review

Arax Advisory Partners increased its Select Medical (SEM) stake by 462% in Q2 2026, buying an estimated $185K and bringing the position to 13,693 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #2168.

Arax Advisory Partners first reported a position in SEM in Q2 2024 and has held it in 9 quarters since. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Arax Advisory Partners held 13,693 shares of Select Medical worth $226K as of Q2 2026.
Arax Advisory Partners bought 11,257 Select Medical shares in Q2 2026, an estimated $185K.
Select Medical made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2168 holding.
Arax Advisory Partners first reported a position in Select Medical in Q2 2024 and has held it in 9 quarters since.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.